Mallinckrodt (MNK) wins IPR decisions on INOMax blood-vessel drug - Bloomberg
Go back to Mallinckrodt (MNK) wins IPR decisions on INOMax blood-vessel drug - BloombergMALLINCKRODT PUBLIC LIMITED COMPANY (NYSE: MNK) | Delayed: 0.34 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.34 | 52 Week High | $85.83 | |||
Open | $0.34 | 52 Week Low | $50.90 | |||
Day High | $0.34 | P/E | 0.34 | |||
Day Low | $0.34 | EPS | $1.00 | |||
Volume | 447 |